Renaissance Capital logo

BIAF News

US IPO Weekly Recap: Summer IPO market ends with more small deals

ALEF

The long Labor Day weekend is here, which means the summer IPO market has come to an end. Four small issuers began trading this past week, although only two met our tracking criteria. Just two IPOs and one SPAC submitted initial filings. The most notable news of the week came from the pipeline. Digital ad firm Aleph Group (ALEF) and car sharing platform...read more

Lung cancer diagnostics developer bioAffinity Technologies prices IPO at $6.13 midpoint

BIAF

bioAffinity Technologies, which is developing a noninvasive test for early detection of lung cancer, raised $8 million by offering 1.3 million units at $6.13, the midpoint of the range of $6 to $6.25. Insiders had indicated on 8% of units in the offering. Each unit consists of one share of common stock, one tradeable warrant exercisable at $7.35, and one non-tradeable warrant...read more

US IPO Week Ahead: Hemp cigarette micro-cap to debut as August IPO market closes out

HPCO

As August comes to an end, the US IPO market looks to close out the month with three small deals, though only one meets our tracking criteria. Other small deals may also join the calendar during the week. Hemp cigarette manufacturer Hempacco (HPCO) plans to raise $6 million at a $138 million market cap. The company’s products are sold in over 200 retail...read more

Lung cancer diagnostics developer bioAffinity Technologies increases deal size by 11% ahead of $8 million unit offering

BIAF

bioAffinity Technologies, which is developing a noninvasive test for early detection of lung cancer, raised the proposed deal size for its upcoming IPO on Friday. The San Antonio, TX-based company now plans to raise $8 million by offering 1.3 million units at a price range of $6 to $6.25. The company had previously filed to offer 1.2 million units at a price of $6. Each unit still...read more